Αρχική World News FDA Grants Accelerated Approval to Zenocutuzumab-zbco for Non-Small Cell Lung Cancer and... World News FDA Grants Accelerated Approval to Zenocutuzumab-zbco for Non-Small Cell Lung Cancer and Pancreatic Adenocarcinoma Από Ogkologos - 10 Ιανουαρίου, 2025 1000 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the eNRGy study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ AI for early cancer detection: where are we now? Could virtual reality become a reality in cancer supportive care? EMA recommends granting a marketing authorisation for daraxonrasib MOST POPULAR Mortality Trends for Most Cancers Remain Favourable In the EU, Although... 27 Ιανουαρίου, 2026 Investigating suspected prostate cancer: improving GP-patient communication 6 Οκτωβρίου, 2021 Cancer Survivor Kicked Out Of Bridal Party Cause She Refused To... 29 Αυγούστου, 2019 Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up 22 Δεκεμβρίου, 2023 Φόρτωση περισσοτέρων HOT NEWS 癌症治疗期间如何保证日常活动的安全和独立执行 Study Says Gold Particles Injected into Tumors May Improve Cancer Patients’... FDA Approves Osimertinib with Platinum-Based Chemotherapy for EGFR-mutated Locally Advanced or... Breast Cancer Risk Genes